Evidence map›Paper›PMID 42834108›Full record

ReviewExperimental & molecular medicine2026

Mitophagy in pathogenesis and therapeutic implications for infection.

Bokeum Jung, Bomi Lee, Asmita Sapkota, Taylor Roh, Wonhyoung Seo, Jin Kyung Kim, Eun-Kyeong Jo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bokeum Jung *Department of Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.ORCID http://orcid.org/0009-0003-8264-3228
Bomi Lee *Department of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Asmita SapkotaDepartment of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Taylor RohDepartment of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0002-6399-1257
Wonhyoung SeoDepartment of Internal Medicine, Division of Hematology/Oncology, Chungnam National University Hospital, Daejeon, Republic of Korea.
Jin Kyung KimDepartment of Microbiology, School of Medicine, Keimyung University, Daegu, Republic of Korea.ORCID http://orcid.org/0000-0002-2051-5787
Eun-Kyeong JoDepartment of Microbiology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. hayoungj@cnu.ac.kr.ORCID http://orcid.org/0000-0001-7191-0587

Funding

Korea Health Industry Development Institute (KHIDI) RS-2025-02215282National Research Foundation of Korea (NRF) RS-2023-00255021National Research Foundation of Korea (NRF) RS-2025-00513245National Research Foundation of Korea (NRF) RS-2026-25501101
6 · The paper itself

Abstract

Mitophagy, a critical selective autophagy pathway targeting dysfunctional mitochondria, is involved in cellular homeostasis and quality control under various stressors. During infection, invading pathogens cause mitochondrial abnormalities that trigger mitophagy. Most bacteria and viruses can exploit mitophagy as a pro-pathogenic process to escape host antiviral responses during infection. Emerging evidence suggests that restoring mitophagy is beneficial for mitigating excessive inflammation, such as in sepsis, whereas mitophagy blockade can activate host defense during bacterial and viral infections. Here we review current knowledge on the role of mitophagy in bacterial and viral infections and sepsis, focusing on the mechanisms by which pathogens evade mitophagy or influence pathogenesis through mitophagy during different types of infection. We also highlight the potential beneficial effects of mitophagy modulators, reagents and small molecules against sepsis-induced pathologies and infections. Progress in these areas will expand our knowledge on alleviating pathology, promoting antimicrobial immune responses and maintaining cellular homeostasis, ultimately providing potential preventive and therapeutic strategies against pathogenic infections and inflammation associated with dysregulated mitophagy.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.